食管胃交界处
腺癌
医学
内科学
肿瘤科
放射科
普通外科
癌症
作者
Daiki MIHARA,Kazuya Kuwada,Tomohiro Hamazaki,Kazuya Namba,Tatsuya Takahashi,Kiyoto Takehara,Takashi Kuise,Masatoshi Kuroda,Toshihisa Yamano,S. Takagi,Eiji Ikeda,Masaichi Kemmotsu,Tomoka Ikeda
出处
期刊:PubMed
日期:2022-06-01
卷期号:49 (6): 693-696
摘要
Although neoadjuvant chemotherapy(NAC)is an effective treatment option for advanced adenocarcinoma at the esophagogastric junction (AEG), there is no sufficient evidence of this in Japan. We report a case of advanced AEG with pathological complete response(pCR)after NAC with S-1 and oxaliplatin(SOX). A 39-year-old man was diagnosed with advanced AEG cT3(SS)N0M0, cStage ⅡB. A total of 3 courses of SOX was administered. After the chemotherapy, the primary tumor showed a significant reduction in size. Subsequently, laparoscopic proximal gastrectomy, D1+ lymphadenectomy and double-flap technique reconstruction were performed. Histopathological examinations showed no residual cancer cells in the resected specimen. Thus, preoperative SOX therapy can be one of the useful treatment strategies for advanced AEG.
科研通智能强力驱动
Strongly Powered by AbleSci AI